DALLAS, July 1, 2015 /PRNewswire/ --
According to a new market research report "Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral), by Application (Biomedical, Protein Production) - Analysis & Global Forecast to 2020", published by MarketsandMarkets, the Transfection Reagents and Equipment Market is expected to reach around $957.9 Million by 2020 with a CAGR of 7.2% from 2014 to 2019.
Browse 116 market Tables and 33 Figures spread through 233 Pages and an in-depth TOC on "Transfection Reagents and Equipment Market"
Early buyers will receive 10% customization on this report.
This report studies the global transfection reagents and equipment market from 2015 to 2020. This market is expected to reach $957.9 million by 2020 from $676.8 million in 2015, at a CAGR of 7.2% during the forecast period.
The global transfection reagents and equipment market is segmented on the basis of product, method, application, and region.
Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=139141146
Based on product, the transfection reagents and equipment market is categorized into reagents and equipment. In 2015, the reagents segment is estimated to account for the largest share of the transfection reagents and equipment market. However, the equipment market is likely to grow at a higher CAGR in comparison to the reagents market.
On the basis of method, this market is segmented into biochemical, physical, and viral methods. In 2015, the biochemical method segment is expected to account for the largest share of the transfection reagents and equipment market, while the viral method segment is expected to grow at the highest CAGR during the forecast period. The biochemical method segment is further classified into calcium phosphate, lipofection DEAE-dextran, and dendrimers. Whereas, the physical method segment is further divided into electroporation, nucleofection, and others (Gengun, sonoporation, magnetofection, and optoinjection among others)
Based on application, the market is segmented into biomedical research, protein production, and therapeutic delivery. In 2015, the biomedical research segment is estimated to account for the largest share of the transfection reagents and equipment market.
On the basis of region, the global transfection reagents and equipment market is divided into North America, Europe, Asia-Pacific, and rest of the world (RoW). The rest of the world comprises Latin America, Middle East, and Africa. In 2015, North America is poised to account for the largest share of the transfection reagents and equipment market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.
Over the years, the transfection reagents and equipment market has witnessed various technological advancements to meet the needs of researchers and biotechnology and pharmaceutical companies. These advancements have led to the development of high throughput large scale transfection instruments and transfection reagents with high efficiency. Advanced technologies result in efficient quantitative and qualitative transfection in varied types of cells, including the hard-to-transfect cell lines.
Some of the major players in the global Transfection Reagents And Equipment Market include Thermo Fisher Scientific, Inc. (U.S.), Promega Corporation (U.S.), Roche (Switzerland), Qiagen N.V. (Netherlands), Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and Maxcyte Inc. (U.S.) among others.
Browse Related Reports:
Biotechnology Reagents Market by Technology (PCR, Cell Culture, Expression & Transfection, Chromatography, Mass Spectrometry, Electrophoresis, & Flow Cytometry), Applications (Protein Purification, Gene Expression, DNA & RNA Analysis, & Drug Testing) and End-Users - Current Trends, Opportunities and Global Forecasts to 2016
Genome Editing / Genome Engineering Market by Application (Cell Line Engineering, Animal & Plant Genetic Engineering), Technology (CRISPR, Antisense, TALEN, Zinc Finger Nuclease) & End User (Biotechnology & Pharmaceutical, CRO) - Global Forecast to 2019
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets